Diagnosis and treatment of autoimmune hepatitis

被引：27
作者：
John M. Vierling
机构：
[1] Liver Center, Baylor College of Medicine, St. Luke's Episcopal Hospital, Houston, TX 77030
来源：
Current Gastroenterology Reports | 2012年 / 14卷 / 1期
关键词：
Associated immunological diseases; Autoantibodies; Autoimmune hepatitis; Diagnosis; Drug-induced liver injury; Hepatocellular carcinoma; Immunosuppression; Liver transplantation; Outcomes; Therapy;
D O I：
10.1007/s11894-011-0236-2
中图分类号：
学科分类号：
摘要：
Autoimmune hepatitis is a chronic liver disease characterized by elevated aminotransferase levels, autoantibodies, increased γ-globulin or IgG levels and biopsy evidence of interface hepatitis. Recent advances include new practice guidelines that redefine criteria for remission to require complete biochemical and histological normalization on therapy; comparisons between the revised original and simplified diagnostic scoring systems; refined characterization of autoantibodies and their diagnostic performance parameters; proof of the safety and efficacy of combination budesonide and azathioprine therapy for non-cirrhotic patients; scrutiny of overlap syndromes; further analyses of the outcomes of orthotopic liver transplantation and the diagnosis and treatment of recurrent and de novo autoimmune hepatitis after transplantation. Anticipated consequences of the application of the new definition of therapeutic remission include a reduction in the proportion of patients achieving remission with conventional immunosuppression regimens and a corresponding increase in the need for alternative therapies. © 2011 Springer Science+Business Media, LLC.
引用
收藏
页码：25 / 36
页数：11
相关论文
共 97 条
  • [1] Manns M.P., Czaja A.J., Gorham J.D., Et al., Diagnosis and management of autoimmune hepatitis, Hepatology, 51, pp. 2193-2213, (2010)
  • [2] Longhi M.S., Ma Y., Mieli-Vergani G., Et al., Aetiopathogenesis of autoimmune hepatitis, J Autoimmun, 34, pp. 7-14, (2010)
  • [3] Ngu J.H., Bechly K., Chapman B.A., Et al., Population-based epidemiology study of autoimmune hepatitis: A disease of older women?, J Gastroenterol Hepatol, 25, pp. 1681-1686, (2010)
  • [4] Ilyas J.A., O'Mahony C.A., Vierling J.M., Liver transplantation in autoimmune liver diseases, Best Pract Res Clin Gastroenterol., 25, pp. 765-82, (2011)
  • [5] Czaja A.J., Freese D.K., Diagnosis and treatment of autoimmune hepatitis, Hepatology, 36, 2, pp. 479-497, (2002)
  • [6] Stravitz R.T., Lefkowitch J.H., Fontana R.J., Et al., Autoimmune acute liver failure: Proposed clinical and histological criteria, Hepatology, 53, pp. 517-526, (2011)
  • [7] Czaja A.J., Autoimmune hepatitis, Clin Liver Dis, 6, (2002)
  • [8] Efe C., Ozaslan E., Nasiroglu N., Et al., The development of autoimmune hepatitis and primary biliary cirrhosis overlap syndrome during the course of connective tissue diseases: Report of three cases and review of the literature, Dig Dis Sci, 55, pp. 2417-2421, (2010)
  • [9] Alvarez F., Berg P.A., Bianchi F.B., Bianchi L., Burroughs A.K., Cancado E.L., Chapman R.W., Cooksley W.G.E., Czaja A.J., Desmet V.J., Donaldson P.T., Eddleston A.L.W.F., Fainboim L., Heathcote J., Homberg J.-C., Hoofnagle J.H., Kakumu S., Krawitt E.L., Mackay I.R., MacSween R.N.M., Maddrey W.C., Manns M.P., McFarlane I.G., Meyer Zum Buschenfelde K.-H., Mieli-Vergani G., Nakanuma Y., Nishioka M., Penner E., Porta G., Portmann B.C., Reed W.D., Rodes J., Schalm S.W., Scheuer P.J., Schrumpf E., Se
  • [10] Hennes E.M., Zeniya M., Czaja A.J., Pares A., Dalekos G.N., Krawitt E.L., Bittencourt P.L., Porta G., Boberg K.M., Hofer H., Bianchi F.B., Shibata M., Schramm C., De Torres B.E., Galle P.R., McFarlane I., Dienes H.-P., Lohse A.W., Simplified criteria for the diagnosis of autoimmune hepatitis, Hepatology, 48, 1, pp. 169-176, (2008)
12345678910